J&J unit begins clinical trial of Incraft stent

04/13/2010 | Clinica (subscription required)

Johnson & Johnson's Cordis unit has begun a nonrandomized trial designed to test the ability of its Incraft stent in treating patients with abdominal aortic aneurysm. The device features an ultra-low-profile delivery system and can be tailored to an individual patient during implantation.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA